Mannkind (MNKD) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mannkind Corporation  (NASDAQ: MNKD)


Mannkind's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Mannkind's ROA in the second quarter of 2026?
Mannkind Corporation recorded a cumulative net loss of $-44 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -6.3%.

However, within the Healthcare sector 268 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 2493 to 2908.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 77.17 % 80.09 % 101.64 % 6.36 % -4.49 %
Y / Y Net Income Change - - - -30.87 % -
Net Income (TTM) in million -44 -24 6 29 33
Return On Assets (TTM) -6.3 % -3.9 % 1.11 % 6.8 % 7.77 %
MNKD's Total Ranking # 2908 # 2493 # 898 # 814 # 892
Total Assets (TTM) in million 732 744 797 497 413
Seq. Total Assets Change -1.63 % -6.62 % 60.48 % 20.19 % -0 %
Seq. Net Income Change - - - 1095.36 % -94.92 %

MNKD's 5 Years Annual ROA >> Back to MNKD Management Effectiveness >> Compare MNKD ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 91
Sector # 269
Overall # 3024

Return On Assets Statistics
High Average Low
140.13 %
-53.53 %
-228.34 %
(Jun 30 2017)   (Jun 30 2016)





Financial Statements
Mannkind's Assets $ 732 million MNKD's Balance sheet
Mannkind's Income $ -19 million Quarterly MNKD's Income Statement
MNKD's Income by Division See MNKD's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 101.64 % -17.08 % - - 195.71 %
Total Assets in million 797 395 477 0 321
Y / Y Net Income Change -78.75 % - - - -
Net Income in million 6 28 -12 -87 -81
Annual Return On Assets 0.74 % 6.98 % -2.5 % - -25.2 %

MNKD's 5 Years Annual ROA >> Back to MNKD Management Effectiveness >> Compare MNKD ROA to its Competitors



Comment on MNKD's ROA in the fiscal year ending 2025
In the fiscal year 2025 Mannkind's ROA decreased compared to previous year to 0.74 %, due to deterioration of net income -78.75 % to $5.86 million, from $27.59 million a year ago, as MNKD's assets were $797.19 million.


More Return On Assets Ratios
MNKD's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MNKD's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MNKD's Competitors
Subscribers only: Roa for Mannkind's Suppliers
Subscribers only: Return On Assets for MNKD's Customers

You may also want to know
MNKD's Roi MNKD's Inventory Turnover Ratio MNKD's Growth Rates MNKD's Dividend Comparisons
MNKD's Profitability Ratios MNKD's Asset Turnover Ratio MNKD's Dividend Growth
MNKD's Roe MNKD's Valuation Ratios MNKD's Financial Strength Ratios MNKD's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-11T09:42:35+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.